ストックスクリーナーアプリを入手
5.53
0.09%
-0.08
アフターアワーズ：
5.37
-0.16
-2.89%
前日終値:
$5.61
開ける：
$5.63
24時間の取引高:
17,853
Relative Volume:
0.13
時価総額：
$18.98M
収益：
-
当期純損益:
$-13.52M
株価収益率:
-7.473
EPS:
-0.74
ネットキャッシュフロー:
$-10.03M
1週間 パフォーマンス:
+6.36%
1か月 パフォーマンス:
-0.20%
6か月 パフォーマンス:
+98.90%
1年 パフォーマンス:
-18.77%
1日の値動き範囲:
$5.3688
$5.8731
1週間の範囲:
$4.30
$6.01
52週間の値動き範囲:
$1.866
$15.80
Kazia Therapeutics Limited Adr Stock (KZIA) Company Profile
名前
Kazia Therapeutics Limited Adr
セクター
電話
01161298780088
住所
140 WICKS RD, NEW SOUTH WALES 2113, NSW
KZIA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| KZIA | 5.53 | 18.98M | 0 | -13.52M | -10.03M | -0.74 |
| VRTX | 450.37 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Kazia Therapeutics Limited Adr Stock (KZIA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-10-14 | 開始されました | Maxim Group | Buy |
| 2021-01-05 | 開始されました | H.C. Wainwright | Buy |
Kazia Therapeutics Limited Adr (KZIA) 最新ニュース
SEC Form 424B3 filed by Kazia Therapeutics Limited - Quantisnow
Kazia sets FDA meeting for glioblastoma drug pathway - Investing.com India
Kazia Therapeutics Announces Granting of Type C Meeting with FDA to Discuss Potential Next Steps for Paxalisib in the Treatment of Newly Diagnosed Glioblastoma Multiforme - StockTitan
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.65% - MSN
Leptomeningeal Metastases Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Y-mAbs Therapeutics, Plus Therapeutics, AngioChem, AstraZeneca - The Globe and Mail
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.65% - MSN
Upcoming Stock Splits This Week (October 28 to November 1) – Stay Invested - Nasdaq
Ratios in Focus: Analyzing Kazia Therapeutics Limited ADR (KZIA)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Kazia Therapeutics Stock Scheduled to Reverse Split on Monday, October 28th (NASDAQ:KZIA) - Defense World
Paxalisib shows promise in brain metastasis treatment - Investing.com
It makes sense and dollars to buy Kazia Therapeutics Limited ADR (KZIA) stock - SETE News
Market Recap: Kazia Therapeutics Limited ADR (KZIA)’s Positive Momentum, Closing at 0.43 - The Dwinnex
Kazia Therapeutics Announces Presentation of Promising Phase I Data Evaluating Concurrent Paxalisib and Radiation Therapy in Patients with Solid Tumor Brain Metastases or Leptomeningeal Metastases Harboring PI3K Pathway Mutations at the American - StockTitan
Kazia Therapeutics Limited ADR (KZIA) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Kazia Therapeutics Limited ADR (KZIA) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
China Vanke Co., Ltd. (OTCMKTS:CHVKY) Short Interest Update - Defense World
Kazia Therapeutics (NASDAQ:KZIA) Stock Price Down 3.6% - Defense World
KZIAKazia Therapeutics Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan
Kazia Therapeutics Announces Presentation of EVT801 Clinical Data at 15th Biennial Ovarian Cancer Research Symposium - StockTitan
The Psychology of Kazia Therapeutics Limited ADR Inc. (KZIA) Price Performance: Understanding Market Sentiment - The InvestChronicle
Financial Health Report: Kazia Therapeutics Limited ADR (KZIA)’s Ratios Tell a Tale - The Dwinnex
Take off with Kazia Therapeutics Limited ADR (KZIA): Get ready for trading - SETE News
Did Kazia Therapeutics Limited ADR (KZIA) perform well in the last session? - US Post News
Daily Progress: Kazia Therapeutics Limited ADR (KZIA) Drop -5.25, Closing at 0.35 - The Dwinnex
Kazia secures exclusive license for cancer therapy - Investing.com
KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER - StockTitan
Pfizer (NYSE:PFE) and Kazia Therapeutics (NASDAQ:KZIA) Critical Comparison - Defense World
Kazia Therapeutics Limited ADR (KZIA) stock analysis: A comprehensive overview - US Post News
Kazia Therapeutics Limited ADR (KZIA) Stock: A Year of Highs and Lows - The InvestChronicle
Kazia Therapeutics Limited ADR (KZIA) is a good investment, but the stock may be undervalued - US Post News
Kazia Therapeutics Limited ADR Inc. (KZIA) Price Performance: A Technical Analysis Perspective - The InvestChronicle
KAZIA ANNOUNCES NON-BINDING LETTER OF INTENT FOR THE PROPOSED GR - GuruFocus.com
Investing in Kazia Therapeutics Limited ADR (KZIA) might be a great opportunity, but the stock is a bit undervalued - US Post News
Kazia Therapeutics Limited ADR (KZIA)’s Day in Review: Closing at 0.40, Up by 3.90 - The Dwinnex
Healthy Upside Potential: Kazia Therapeutics Limited ADR (KZIA) - SETE News
Analytical Overview: Kazia Therapeutics Limited ADR (KZIA)’s Ratios Tell a Financial Story - The Dwinnex
The Kazia Therapeutics Limited ADR (KZIA) had a good session last reading, didn’t it? - US Post News
OppFi Inc (OPFI)’s results reveal risk - US Post News
Kazia Therapeutics Limited ADR Inc. (KZIA) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
There is no way Kazia Therapeutics Limited ADR (KZIA) can keep these numbers up - SETE News
KZIA’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
What Analysts Were Expecting After Kazia Therapeutics Limited ADR (NASDAQ: KZIA) rose 15.50% - Stocks Register
Closing Strong: Kazia Therapeutics Limited ADR (KZIA) Ends at 0.32, Down -7.80 from Last Close - The Dwinnex
Kazia Therapeutics Limited ADR (KZIA) can make a big difference with a little luck - SETE News
Was there any good news for Kazia Therapeutics Limited ADR (KZIA) stock in the last session? - US Post News
In the Green: Kazia Therapeutics Limited ADR (KZIA) Closes at 0.40, Up/Down -3.38 from Previous Day - The Dwinnex
Short Interest in Kazia Therapeutics Limited (NASDAQ:KZIA) Increases By 7,076.2% - Defense World
Stock Market Recap: Kazia Therapeutics Limited ADR (KZIA) Concludes at 0.42, a 15.59 Surge/Decline - The Dwinnex
Biotech Stock Laboratory: Try a Small Experiment With Kazia Therapeutics - InvestorPlace
Wall Street Analyst Initiated Kazia Therapeutics Limited ADR [KZIA]. What else is Wall St. saying - The DBT News
Kazia Therapeutics Limited ADR (KZIA) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Kazia Therapeutics Limited Adr (KZIA) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
3.56%
大文字化:
|
ボリューム (24 時間):